deltatrials
Recruiting PHASE3 INTERVENTIONAL 2-arm NCT03083184

Evaluation of the Efficacy of an inTerdialytic Ethanol 40% v/v - enoxapaRin 1000 U/mL Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients (ETERNITY)

Evaluation of the Efficacy of an inTerdialytic Ethanol 40% v/v - enoxapaRin 1000 U/mL Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients: a mulTi-centre, Randomized, Single Blind, Parallel Group studY (ETERNITY)

Sponsor: CH du Puy en Velay, Hôpital Emile Roux

Updated 9 times since 2017 Last updated: Dec 7, 2023 Started: Feb 9, 2018 Primary completion: Dec 31, 2026 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Tunnelled Hemodialysis Catheter Infection and is currently actively recruiting participants. CH du Puy en Velay, Hôpital Emile Roux leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Apr 2017 – ~Feb 2018 · 10 months · monthly snapshotNot Yet Recruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshotNot Yet Recruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotNot Yet Recruiting~Oct 2021 – ~Jan 2024 · 27 months · monthly snapshotUnknown Status~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – present · 23 months · monthly snapshotRecruiting

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Recruiting PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  3. Jan 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

    Status: Unknown StatusRecruiting

  4. Oct 2021 — Jan 2024 [monthly]

    Unknown Status PHASE3

    Status: Not Yet RecruitingUnknown Status

  5. Jan 2021 — Oct 2021 [monthly]

    Not Yet Recruiting PHASE3

Show 4 earlier versions
  1. Sep 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE3

  2. Jun 2018 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE3

  3. Feb 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

  4. Apr 2017 — Feb 2018 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CH du Puy en Velay, Hôpital Emile Roux
  • CHU Hôpital Maison Blanche, 45 Rue Cognacq-Jay 51092 REIMS Cedex
  • Calydial
  • Centre de dialyse d'Alès
  • Centre de néphrologie Polyclinique Médipôle Saint-Roch, Rue Ambroise Croizat
  • Centre hospitalier de Chambéry
  • Centre hospitalier de Perpignan
  • Hôpital Edouard Herriot
  • Hôpital Lapeyronie
  • Ministry of Health, France
  • Nouvel Hôpital Civil, 1 place de l'Hôpital 67091 Strasbourg cedex
  • University Hospital of Saint-Etienne
  • University Hospital, Clermont-Ferrand
  • University Hospital, Toulouse
Data source: University Hospital, Clermont-Ferrand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations